On Friday, shares of Axonics, Inc. (NASDAQ:AXNX – Get Rating) reached a new 52-week high. The highest price the company traded at was $77.19,

and the last price it traded at was $76.80. A total of 942,450 shares changed hands. The last price of the stock was $75.48. Upgrades and downgrades by analysts 

Several research reports have been written about AXNX in the last year or so. In a research note released on Tuesday, August 2nd, Morgan Stanley

raised its price target for Axonics shares from $73.00 to $80.00 and gave the company an "overweight" rating. In a research note released on

Tuesday, August 2nd, Needham & Company LLC raised their price target for shares of Axonics from $60,000 to $77,000 and gave the stock a "buy"

rating. In a research note released on Tuesday, August 2nd, Wells Fargo & Company raised their price target for Axonics shares from $80 to $87 and

gave the stock an "overweight" rating. In a research note released on Tuesday, August 2nd, Piper Sandler raised their price target for Axonics shares

from $77.00 to $82.00 and gave the stock an "overweight" rating. In a research note released on Tuesday, August 2nd, Truist Financial raised their

target price for Axonics shares from $75.00 to $85.00 and gave the stock a "buy" rating. The stock has been given a buy rating by eight analysts.

According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $77.86.